gemcitabine has been researched along with Phlebitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goto, K; Kakinuma, R; Kubota, K; Niho, S; Nishiwaki, Y; Ohmatsu, H; Yoh, K | 1 |
Akasaka, H; Hara, Y; Hashimoto, H; Hayashi, K; Inokuchi, M; Kasahara, K; Miyamoto, K; Nakamura, M; Nishigami, J; Nishimura, G; Shimizu, M; Suga, Y; Yonejima, M | 1 |
2 other study(ies) available for gemcitabine and Phlebitis
Article | Year |
---|---|
High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Mitomycins; Phlebitis; Retrospective Studies; Risk Factors; Vinblastine; Vinorelbine | 2004 |
[Consideration of preventive free-flowing IV infusion method for vinorelbine].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gemcitabine; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Phlebitis; Trastuzumab; Vinblastine; Vinorelbine | 2007 |